Global Atopic Dermatitis Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug Class;

Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Antibiotics, Calcineurin Inhibitors and Other Drug Classes.

Segmented by Route of Administration;

Topical, Oral and Injectable.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn951538772 Published Date: April, 2024 Updated Date: May, 2024
Download Free Sample NowDownload Free Sample Now

Introduction

Global Atopic Dermatitis Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 57.7
2021 65.4
2022 70.8
2023 77.0
2024 91.8
2025 96.7
2026 105.5
2027 122.1
2028 143.5
2029 156.0
2030 164.1

In the year 2023, the Global Atopic Dermatitis Market was valued at USD 11,518.61 million. The size of this market is expected to increase to USD 30,826.72 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 15.1%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Atopic Dermatitis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Burden of Allergic Reactions with Major Role of Food Allergy
        2. Increasing Environmental Pollution
      2. Restraints
        1. Serious Adverse Effects Related to Certain Therapeutic Drugs
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Atopic Dermatitis Market, By Drug Class, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Corticosteroids
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Emollients/Moisturizers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. IL-4 and PDE4 Inhibitors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Antibiotics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Calcineurin Inhibitors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Other Drug Classes
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Atopic Dermatitis Market, By Route of Administration, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Topical
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Injectable
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Atopic Dermatitis Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Abbvie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Allergan PLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Bausch Health Companies Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Encore Dermatology Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. GlaxoSmithKline PLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Nestle SA
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Novartis International AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Atrial Fibrillation
Global Atrial Fibrillation Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Atrial Fibrillation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Autism Spectrum Disorder Therapeutics
Global Autism Spectrum Disorder Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Autism Spectrum Disorder Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Autoimmune Therepeutics
Global Autoimmune Disease Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Autoimmune Disease Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Autologous Stem Cell and Non-Stem Cell-Based Therapies
Global Autologous Stem Cell and Non-Stem Cell-Based Therapies Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Autologous Stem Cell and Non-Stem Cell-Based Therapies Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...